EKF Diagnostics (LON:EKF) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 25.73 and traded as high as GBX 25.90. EKF Diagnostics shares last traded at GBX 24.60, with a volume of 72,517 shares changing hands.

EKF Diagnostics Price Performance

The company’s 50 day moving average price is GBX 24.93 and its 200-day moving average price is GBX 25.73. The company has a market cap of £106.05 million, a price-to-earnings ratio of 52.34 and a beta of 0.49. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16.

EKF Diagnostics (LON:EKF) last released its earnings results on Tuesday, March 24th. The company reported GBX 0.47 EPS for the quarter. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%. On average, equities research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.